Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 422

Results For "MS"

5461 News Found

DSM, UNICEF and Sight and Life extend global partnership to address malnutrition
Healthcare | May 11, 2022

DSM, UNICEF and Sight and Life extend global partnership to address malnutrition

The partners also aim to expand their work to Latin America for the first time


Bayer posts higher sales, profit in first quarter
News | May 11, 2022

Bayer posts higher sales, profit in first quarter

Company's net income rose by 57.5 percent to 3.291 billion euros in Q1


Myovant Sciences and Accord Healthcare partner to commercialise Orgovyx in Europe
Biotech | May 10, 2022

Myovant Sciences and Accord Healthcare partner to commercialise Orgovyx in Europe

Myovant to receive an upfront payment of US $50 million, is eligible to receive commercial launch, sales-based and other milestones totaling up to US $90.5 million


Emcure launches EmWocal campaign to raise women’s health issues
Healthcare | May 10, 2022

Emcure launches EmWocal campaign to raise women’s health issues

The campaign will be available in nine Indian languages namely Hindi, English, Odia, Marathi, Tamil, Telugu, Kannada, Malayalam and Bengali


Novo Nordisk and Flagship Pioneering partner to create a portfolio of transformational medicines
Biotech | May 10, 2022

Novo Nordisk and Flagship Pioneering partner to create a portfolio of transformational medicines

Pioneering Medicines and Novo Nordisk Bio Innovation Hub will leverage Flagship Pioneering’s bioplatform companies to create a portfolio of research programmes within cardiometabolic and rare diseases


Omega Healthcare to expand operations in India
Healthcare | May 10, 2022

Omega Healthcare to expand operations in India

Omega plans to further strengthen its capabilities, deepen domain expertise and build new solutions


CEPI partners with Bharat Biotech, Unversity of Sydney and ExcellGene to develop variant proof Covid-19 vaccine
Biotech | May 10, 2022

CEPI partners with Bharat Biotech, Unversity of Sydney and ExcellGene to develop variant proof Covid-19 vaccine

CEPI will provide funding of up to US $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multidisciplinary consortium


Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion
Biotech | May 10, 2022

Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion

Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need


Roche Diabetes Care launches ACCU-FINE pen needles for virtually painless insulin delivery
Biotech | May 09, 2022

Roche Diabetes Care launches ACCU-FINE pen needles for virtually painless insulin delivery

Aims to increase compliance and improve outcomes for People with Diabetes (PwD)


InxMed raises US $ 15 million in Series B+ financing
Startup | May 09, 2022

InxMed raises US $ 15 million in Series B+ financing

The plan is to advance innovative therapies to drug-resistant cancers